Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

824
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
824
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

265
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
265
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

220
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
220
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

369
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
369
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

352
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
352
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

312
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
312

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Z-scores for Spirometry Interpretation: Implications for Classifying Impairments in Lung Function.

Annals of the American Thoracic Society·2026
Same author

Association Between Chronic PM2.5 Exposure and CT-Detected Lung Abnormalities in the SPIROMICS Cohort.

Annals of the American Thoracic Society·2026
Same author

Indoor spaces as active protectors of respiratory health.

American journal of respiratory and critical care medicine·2026
Same author

Exploring the Impact of Financial Toxicity in COPD: A Qualitative Study.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same author

Indoor Air Pollution and COPD Morbidity in Rural Appalachian Cohorts.

Annals of the American Thoracic Society·2026
Same author

Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same journal

Response to the Letter to the Editor Regarding "Comparative Evaluation of Risk Scores for Predicting Postoperative Pulmonary Complications".

Respiratory care·2026
Same journal

Respiratory Muscle Dysfunction in Stable COPD: A Multimodal Assessment of Diaphragmatic and Cough-Related Impairment.

Respiratory care·2026
Same journal

Flow Asynchronies During Pressure Support Ventilation in Children: A Bench Model Study.

Respiratory care·2026
Same journal

Inspiratory Effort Assessment Using the Occlusion Pressure-Derived Tension-Time Index.

Respiratory care·2026
Same journal

Clinical Usage of High-Flow Nasal Cannula Across Disease Categories and Care Settings: A Nationwide Cohort Study in Japan.

Respiratory care·2026
Same journal

Efficacy of Mechanical Insufflation-Exsufflation Devices as Analyzed in Lung Models: Systematic Review and Network Meta-Analysis of Peak Expiratory Flow Data.

Respiratory care·2026
See all related articles

Related Experiment Video

Updated: Feb 10, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K

Medication Regimens for Managing COPD Exacerbations.

Nirupama Putcha1, Robert A Wise2

  • 1Johns Hopkins University School of Medicine (Pulmonary and Critical Care Medicine), Baltimore, Maryland.

Respiratory Care
|May 26, 2018
PubMed
Summary
This summary is machine-generated.

Managing exacerbations of chronic obstructive pulmonary disease (COPD) involves bronchodilators, corticosteroids, and antibiotics. This review examines optimal drug selection, dosage, and duration for COPD exacerbations.

Keywords:
COPDantibioticsbronchodilatorscorticosteroidpharmacotherapy

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.5K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.0K

Related Experiment Videos

Last Updated: Feb 10, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.5K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.5K
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
06:43

Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management

Published on: November 21, 2017

25.0K

Area of Science:

  • Pulmonology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Exacerbations are a primary driver of morbidity and mortality in chronic obstructive pulmonary disease (COPD).
  • Current guidelines recommend bronchodilators, corticosteroids, and antibiotics for COPD exacerbations.
  • Significant uncertainty persists regarding optimal pharmacotherapeutic strategies for managing COPD exacerbations.

Purpose of the Study:

  • To review the existing evidence base for pharmacotherapy in COPD exacerbations.
  • To synthesize expert recommendations for drug selection, dose, route, and duration of treatment.
  • To provide guidance for managing COPD exacerbations in both outpatient and inpatient settings.

Main Methods:

  • Literature review of evidence supporting pharmacotherapy for COPD exacerbations.
  • Analysis of expert consensus and clinical guidelines.
  • Synthesis of data pertaining to outpatient and inpatient treatment strategies.

Main Results:

  • Strong evidence supports the use of corticosteroids for exacerbations and antibiotics in acute hospital settings.
  • Considerable uncertainty remains regarding optimal drug selection, dosage, route, and treatment duration.
  • The review consolidates current evidence and expert opinions for practical application.

Conclusions:

  • Pharmacotherapy, including bronchodilators, corticosteroids, and antibiotics, is central to managing COPD exacerbations.
  • Further research and guideline refinement are needed to address uncertainties in treatment specifics.
  • This review offers a comprehensive overview to guide clinical decision-making for COPD exacerbations.